Serapha Bio
PrivateLast Round
Series A
Jun 23, 2026
Est. Valuation
$303.7M
Company Overview
Serapha Bio is a biotechnology company developing an investigational in vivo base editing therapy for Alpha-1 Antitrypsin Deficiency (AATD).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Serapha Bio Comparables
Compare Serapha Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AIRNA | 89% | |
| Beam Therapeutics | 88% | |
| Frequency Therapeutics | 87% |
Serapha Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 23, 2026 |
Serapha Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series A |
| Balyasny Asset Management L.P. | Series A |
| RA Capital Management | Series A |
| LifeSci Venture Partners | Series A |
| Eventide Funds | Series A |
| Logos Capital | Series A |
| Casdin Capital | Series A |
Serapha Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Serapha Bio's valuation, stock price, and market status.
Is Serapha Bio a public or private company?
Serapha Bio is a private company.
What is the current stock price of Serapha Bio?
Serapha Bio is a private company with no public stock price. Caplight tracks Serapha Bio's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Serapha Bio worth (valuation)?
Serapha Bio's valuation is estimated at $303.7M based on funding round data.
Can I buy Serapha Bio stock?
Serapha Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Serapha Bio's last funding round?
Serapha Bio's most recent funding round was Series A on June 23, 2026.
Who are the main investors in Serapha Bio?
Key investors in Serapha Bio include RA Capital Management, RTW Investments.
Will Serapha Bio IPO soon?
No public IPO plans have been announced for Serapha Bio.
How can I track Serapha Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Serapha Bio's secondary market activity and sign up for updates.